- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03379519
Protocol of Multi-domain Attention Training
February 19, 2020 updated by: Yang, Hui-Ling, Ministry of Science and Technology, Taiwan
The Development and Evaluation of Multi-domain Attention Training for Older Adults With Mild Cognitive Impairment
This study sought to investigate the changes in attention in older adults with mild cognitive impairment after Multi-domain Attention Training .
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This double-blind randomized controlled study has a 2-arm parallel group design.
All subjects will be randomized by the block randomization, into intervention group (Multi-domain Attention Training, MAT), or active control group (Passive information activities, PIA).
Training sessions of the MAT group are 45 minutes/day, 3 days/week, for 12 weeks (36 sessions each).
The training of PIA group is the same as MAT group.
The investigators constructed a rigorous MAT program adhering to the Consolidated Standards of Reporting Trials (CONSORT) reporting guidelines.
The investigators expect to determine the improvement in attention function of older adults with mild cognitive impairment after using the MAT program.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participants must endorse at least two items from a list of frequent subjective memory complaints by patient and/or an informant
- Objective memory impairment on neuropsychological tests of memory 1.5 SD or more below age/education norms
- Clinical neurologic examination by the Mini-Mental State Examination (MMSE) score of 24 or higher
- No impairment in personal activities of daily living (P-ADL) as determined by clinical interview with participant and family
Exclusion Criteria:
- The clinical diagnosis of dementia was based on the DSM-IV-TR
- Active in another cognitive or memory-related training in the past year
- Comorbid medical conditions that would predispose them to imminent functional decline or cognitive impairment
- A diagnosis of major neurological or psychiatric illness history and/or behavioral problems that would sufficiently impair performance to make participation impossible
- Severe losses in vision, hearing, or communicative ability
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Multi-domain Attention Training (MAT)
Training sessions of the MAT group is 45 minutes/day, 3 sessions/week, for 12 weeks (36 sessions).
|
The training content emphasis three concept of attention include: intensity of attention, executive attention, and spatial orienting attention.
Other Names:
|
Active Comparator: Passive information activities (PIA)
The training sessions of PIA is the same as MAT group (45 min/day, 3 days/week, for 12 weeks, for a total of 36 sessions).
|
The active control group (Passive information activities) training content included reading online e-books and playing online games.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in attention as measured by the Digit Span Task (DS).
Time Frame: Change from baseline in executive attention at Immediate post-test, 3 months, 6 months after intervention.
|
The primary outcome indicators is executive attention assessed by the Digit Span Task (DS).
|
Change from baseline in executive attention at Immediate post-test, 3 months, 6 months after intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in attention as measured by the Trail Making Test (TMT).
Time Frame: Change from baseline in spatial orienting attention at Immediate post-test, 3 months, 6 months after intervention.
|
The secondary outcome indicator is spatial orienting attention evaluated by the Trail Making Test.
|
Change from baseline in spatial orienting attention at Immediate post-test, 3 months, 6 months after intervention.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2016
Primary Completion (Actual)
May 31, 2019
Study Completion (Actual)
December 31, 2019
Study Registration Dates
First Submitted
December 10, 2017
First Submitted That Met QC Criteria
December 18, 2017
First Posted (Actual)
December 20, 2017
Study Record Updates
Last Update Posted (Actual)
February 20, 2020
Last Update Submitted That Met QC Criteria
February 19, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- N201602069
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
University of California, San FranciscoNational Institute on Aging (NIA)Active, not recruitingMild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognitive Impairment, Mild | Cognitive Deficits, MildUnited States
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.RecruitingMild Cognitive Impairment (MCI)Taiwan
-
Thomas Jefferson UniversityJohns Hopkins University; University of Pennsylvania; National Institute on Aging... and other collaboratorsCompletedMild Cognitive Impairment (MCI)United States
-
Palo Alto Veterans Institute for ResearchU.S. Army Medical Research and Development CommandCompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Assaf-Harofeh Medical CenterNeurim Pharmaceuticals Ltd.UnknownMild Cognitive Impairment (MCI)Israel
-
Xuanwu Hospital, BeijingWuhan University; Beijing Friendship Hospital; First Affiliated Hospital Xi'an... and other collaboratorsRecruitingAmnestic Mild Cognitive ImpairmentChina
-
Immunotec Inc.RecruitingMild Cognitive Impairment (MCI)Canada
-
Jennifer BramenNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Meir Medical CenterTerminatedMild Cognitive Impairment (MCI)Israel
Clinical Trials on Multi-domain Attention Training (MAT)
-
Wake Forest University Health SciencesNational Institute on Aging (NIA)CompletedAcute Decompensated Heart FailureUnited States
-
University of Milano BicoccaCompletedAge-related Cognitive DeclineItaly
-
Stanford UniversityNational Institute on Aging (NIA)CompletedMild Cognitive ImpairmentUnited States
-
Kazimierz Wielki UniversityNational Science Centre, Poland; John Paul II Catholic University of Lublin...CompletedAging | Cognitive Decline | Old Age; DementiaPoland
-
Beijing Anzhen HospitalBeijing Wispirit Technology Co., LtdNot yet recruitingHypertension | Mild Cognitive ImpairmentChina
-
Xuanwu Hospital, BeijingWuhan University; Beijing Friendship Hospital; First Affiliated Hospital Xi'an... and other collaboratorsRecruitingAmnestic Mild Cognitive ImpairmentChina
-
National Yang Ming UniversityCompleted
-
Geriatric Education and Research InstituteNeeuro Pte Ltd; Ministry of Health, Singapore; ProAge Pte Ltd; KKT Technology Pte...CompletedCognitive Decline | Cognitive Impairment, MildSingapore
-
National Yang Ming UniversityNational Science and Technology CouncilCompletedAge-related Cognitive Decline | Age-related Physiology DeclineTaiwan
-
NeurocoreCompletedMild Cognitive ImpairmentUnited States